Investors

Baker Brothers Investments

Managed by Mr. Julian Baker and Dr. Felix Baker, Baker Brothers Investments is a family of long-term investment funds for major university endowments and foundations that are focused on publicly-traded and privately-held life science companies.

Johnson & Johnson Development Corporation

Organized in 1973, Johnson & Johnson Development Corp. (JJDC) is the venture capital subsidiary of Johnson & Johnson. JJDC makes private equity investments in venture funded healthcare companies. Portfolio investments include those in the field of pharmaceuticals, biotechnology, medical devices, diagnostics and consumer products.

For more information, visit www.jjdevcorp.com.

Lions Capital Corporation

As fund manager of BC Advantage Funds (VCC) Ltd. and the Lions Liquidity Investment Fund I LP, Lions Capital currently manages more than $50 million of investment capital. Lions Capital also provides financing and merger and acquisitions services to life science and technology companies.

For more information, visit www.lionscapital.com.

Pfizer Ventures Investments

Pfizer Venture Investments (PVI), the venture capital arm of Pfizer, Inc, was founded in 2004 and invests for return in areas of current or future strategic interest to Pfizer.  PVI seeks to remain at the forefront of life science advances, looking to identify and invest in emerging companies that are developing compounds and technologies that have the potential to enhance Pfizer’s pipeline and shape the future of our industry.

For more information, visit www.pfizer.com.

Augment Investments Limited

Augment Investments Ltd. is the majority shareholder of OJSC Pharmastandard, a Russian pharmaceutical company.

For more information, visit www.inbiovent.com.

Ventures West 8 LP (VW8LP)

Five Corners Capital Inc. (5CC) is a newly formed investment management company with responsibility as the General Partner of investment partnerships, VW8LP and VW7LP, formerly managed by subsidiaries of Ventures West Capital Ltd.

For more information, visit www.fivecornerscapital.com.